Harel Insurance Investments & Financial Services Ltd. - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
Harel Insurance Investments & Financial Services Ltd. ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$26
-23.5%
1,598
+92.5%
0.00%0.0%
Q2 2023$34
-61.4%
830
-43.5%
0.00%
-50.0%
Q1 2023$88
+46.7%
1,470
+79.3%
0.00%
+100.0%
Q4 2022$60
-99.9%
820
-12.8%
0.00%
-50.0%
Q3 2022$72,000
+2.9%
940
-6.7%
0.00%
+100.0%
Q2 2022$70,000
-43.5%
1,007
-32.6%
0.00%
-50.0%
Q1 2022$124,000
-24.4%
1,493
-27.3%
0.00%
-33.3%
Q4 2021$164,000
+37.8%
2,055
+2.8%
0.00%
-25.0%
Q2 2020$119,0002,0000.00%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 350,884$26,344,0008.01%
HARTLINE INVESTMENT CORP/ 318,109$23,884,0003.27%
Deep Track Capital, LP 550,000$41,294,0002.92%
MORGAN JESS S & CO INC 43,975$3,302,0002.03%
Taylor Frigon Capital Management LLC 46,376$3,482,0001.09%
Darsana Capital Partners LP 258,937$19,441,0000.90%
Private Harbour Investment Management & Counsel, LLC 13,562$1,018,0000.81%
Rhenman & Partners Asset Management AB 120,387$9,610,0000.64%
COURAGE CAPITAL MANAGEMENT LLC 10,000$751,0000.50%
Baillie Gifford 9,615,168$721,906,0000.40%
View complete list of NOVOCURE LTD shareholders